PIONEER: Intraoperative and Perioperative OCT Study

Sponsor
The Cleveland Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT02423161
Collaborator
National Eye Institute (NEI) (NIH)
750
1
72
10.4

Study Details

Study Description

Brief Summary

OCT provides high-resolution information regarding the anatomic structure of the tissues of the eye in a 2-dimensional and 3-dimensional view. Much of this information is not able to be recognized by a clinician. Utilizing this information during surgery will allow for ophthalmic surgeons to better understand how surgical procedures impact the anatomic structure of the eye.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Over the last decade, optical coherence tomography (OCT) has become a critical component to the evaluation of ophthalmic disease. Similar to ultrasound, OCT uses light to reconstruct an image of the tissue of interest. In effect, OCT has become to function as a light biopsy, allowing clinicians to visualize subtle pathologic changes in the tissue, such as macular edema or subretinal fluid. The use of OCT in the clinic setting has become the standard for monitoring diseases such as macular degeneration and diabetic retinopathy. It has quickly become the most frequent ordered diagnostic test in ophthalmology.

    Due to restraints in the size and structure of the imaging equipment, the use of OCT in the operating room has been limited. More recently, modifications to OCT table-top models as well as the development of hand-held OCT probes have allowed for the translation of OCT technology into the operating room. The high resolution anatomic information that is gained from OCT imaging is a natural complement to the ophthalmic surgeon. Using OCT during vitreoretinal surgery has revealed subtle changes in the microarchitecture of the retina in diseases such as retinal detachment, macular hole, and optic pit, that were not previously known. Using OCT during lamellar corneal transplant procedures, anterior segment surgeons have been able to image proper placement of the graft that was previously unattainable with a standard surgical microscopic view.

    Using information gained from OCT, surgeons may be able to improve surgical decision making and improve clinical outcomes. For this study, subjects undergoing ophthalmic surgery, including vitreoretinal surgery and anterior segment surgery, would have OCT imaging performed in the perioperative period, intraoperative period, or both to document architectural changes in the ocular tissues. This information would be prospectively collected and reviewed for associations with anatomic and functional outcomes.

    A microscope-mounted OCT system will be used to assess feasibility and utility of imaging during ophthalmic surgical milestones.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    750 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Prospective Intraoperative and Perioperative Ophthalmic Imaging With Optical Coherence Tomography: PIONEER Study
    Study Start Date :
    Aug 1, 2011
    Actual Primary Completion Date :
    Aug 1, 2014
    Actual Study Completion Date :
    Aug 1, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Feasibility of intraoperative OCT [3 years]

      Defined as percentage of cases where OCT was successfully able to be obtained during surgery

    Secondary Outcome Measures

    1. Utility of intraoperative OCT [3 years]

      Defined as percentage of cases where the OCT altered surgical decision-making based on surgeon-report on questionnaire

    2. Safety of intraoperative OCT [3 years]

      Defined as the percentage of subjects that experience adverse events that were related to the intraoperative OCT and/or in excess of what might be expected relative to the surgery performed

    3. Time requirements for intraoperative OCT [3 years]

      Defined as the mean number of minutes required to completed intraoperative imaging during a surgical case

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • The study population includes any patient requiring ophthalmic surgery
    Exclusion Criteria:
    • Children under the age of 18

    • Cognitive/Mentally impaired or unable to provide consent

    • Media opacity precluding OCT scanning

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cole Eye Institute, Cleveland Clinic Cleveland Ohio United States 44195

    Sponsors and Collaborators

    • The Cleveland Clinic
    • National Eye Institute (NEI)

    Investigators

    • Principal Investigator: Justis P Ehlers, MD, Cole Eye Institute, Cleveland Clinic, OH 44195

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Justis Ehlers, Assistant Professor of Ophthalmology, The Cleveland Clinic
    ClinicalTrials.gov Identifier:
    NCT02423161
    Other Study ID Numbers:
    • 11-787
    First Posted:
    Apr 22, 2015
    Last Update Posted:
    Jan 24, 2018
    Last Verified:
    Jan 1, 2018
    Keywords provided by Justis Ehlers, Assistant Professor of Ophthalmology, The Cleveland Clinic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 24, 2018